PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.41%
Positive revenue growth while 2127.T is negative. John Neff might see a notable competitive edge here.
9.37%
Positive gross profit growth while 2127.T is negative. John Neff would see a clear operational edge over the competitor.
0.78%
Positive EBIT growth while 2127.T is negative. John Neff might see a substantial edge in operational management.
22.36%
Positive operating income growth while 2127.T is negative. John Neff might view this as a competitive edge in operations.
5.48%
Positive net income growth while 2127.T is negative. John Neff might see a big relative performance advantage.
5.48%
Positive EPS growth while 2127.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
5.48%
Positive diluted EPS growth while 2127.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
23.00%
10Y revenue/share CAGR under 50% of 2127.T's 203.66%. Michael Burry would suspect a lasting competitive disadvantage.
-5.88%
Negative 5Y CAGR while 2127.T stands at 184.10%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-32.18%
Negative 3Y CAGR while 2127.T stands at 91.16%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-100.00%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-100.00%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
No Data
No Data available this quarter, please select a different quarter.
38.40%
Below 50% of 2127.T's 275.93%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-5.96%
Negative 5Y net income/share CAGR while 2127.T is 493.39%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-29.07%
Negative 3Y CAGR while 2127.T is 120.10%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
90.52%
Below 50% of 2127.T's 265.63%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
28.29%
Below 50% of 2127.T's 190.83%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-15.26%
Negative 3Y equity/share growth while 2127.T is at 100.41%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-41.67%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
-50.00%
Negative 5Y dividend/share CAGR while 2127.T stands at 3499.88%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
16.67%
Below 50% of 2127.T's 200.00%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
16779.31%
AR growth of 16779.31% while 2127.T is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
3.78%
Inventory shrinking or stable vs. 2127.T's 78.74%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
7.63%
Similar asset growth to 2127.T's 7.94%. Walter Schloss finds parallel expansions or investment rates.
4.31%
75-90% of 2127.T's 5.55%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
12.23%
Debt growth of 12.23% while 2127.T is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
No Data
No Data available this quarter, please select a different quarter.
-45.53%
We cut SG&A while 2127.T invests at 0.90%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.